General Discussion Topics, page-132916

First 132916 Last

Share
Profile

Follow
j1300z

103 Posts.

30

23/02/24

16:21

Post #: 72565305
Share

Originally posted by Silent-Bubbles: ↑

Di no such think Whiskey. Simply called the price targets to a ' T ' before they actually occurred and then like most other investors endeavor to apply some speculation as to what might have occured or was in the works. There was no ramping mate , as most of my comments are actually still in play.

This is obviously in contrast to your contributions whereby you sit back , wade in with your holier than though comments saying there's nothing wrong and nothing to see here. Far from it pal.

You missed seeing the rise mate and then tried to pour cold water on it at every possible comment. I could ask the same questions on you as to Why was that the case. Why do you feel compelled as a so called investor in this stock to do that......

Investors have questions they want answered . And mores so after being blind sided by our so called Joint Venture partner who needed to obtain a waiver just to get their original stake in Sayona Mining ....due their offtake and JV influence and related party status ...., and then just abruptly without notice dumps its stock at a huge discount to the prices being obtained and paid by investors on the uptick.

Not to mention there is this missing 97,601,513 Piedmont shares which obviously were sold prior to the block trade and which were NOT advised to the ASX and Sayona shareholders.

So none of this right from the start of me getting the SP calls spot on are ' Ramping the hell out of the stock '. None of it.

Expand

what are the items that are Still in play from your predictions? What may be pushed out and any thoughts on price levels?

Thanks

SYA Price at posting: 4.2¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 11,433 more messages in this thread...

First 132916 Last

Add SYA (ASX) to my watchlist

(20min delay)
Last 3.5¢		Change 0.004(12.9%)		Mkt cap ! $360.2M

Open	High	Low	Value	Volume
3.3¢	3.6¢	3.2¢	$2.131M	62.72M

Buyers (Bids)

No.	Vol.	Price($)
22	4754875	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.5¢	3389527	14

View Market Depth

No.	Vol.	Price($)
21	4596052	0.034
27	8777488	0.033
29	8553029	0.032
24	10786640	0.031
36	5261630	0.030

Price($)	Vol.	No.
0.035	3389527	14
0.036	13139052	45
0.037	11650673	31
0.038	10624737	24
0.039	4712758	20

Last trade - 16.10pm 07/10/2024 (20 minute delay)

SYA (ASX) Chart

General Discussion Topics, page-132916

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

General Discussion Topics, page-132916

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News